XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Cash Flows - USD ($)
9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Cash flows from operating activities    
Net loss $ (2,111,244) $ (2,009,871)
Adjustments to reconcile net loss to net cash used in by operating activities:    
Stock-based compensation 856,819 749,332
Depreciation 8,225 0
Amortization of intangibles 635,675 0
Deferred tax adjustment 1,587 0
Excess value of common stock issued to settle liabilities 0 265,591
Contract assets (834,824) 0
Prepaid expenses and other current assets 131,582 0
Other receivable, related party (8,064) 0
Amortization of ROU assets 11,071 0
Changes in operating assets and liabilities    
Accounts receivable (183,227) 0
Due to related parties - accrued salary 144,000 72,000
Accounts payable 883,874 36,688
Lease liability (11,071) 0
Accrued expenses and other current liabilities (112,523) 0
Contract liabilities 84,687 0
Net cash used in operating activities (503,433) (886,260)
Cash flows from investing activities    
Cash and restricted cash acquired from business combination 297,421 5,955
Purchase of property, plant and equipment (39,500) 0
Software development capitalization (67,022) 0
Deposit paid for acquisition 0 (134,862)
Net cash provided by (used in) investing activities 190,899 (128,907)
Cash flows from financing activities    
Short-term advances, related party 219,588 45,500
Repayment of loan (915) 0
Short-term loan 10,000 0
Proceeds from sale of common stock 404,970 1,160,040
Net cash provided by financing activities 633,643 1,205,540
Effect of exchange rate changes on cash and cash equivalents 18,817 1
Net change in cash and cash equivalents 339,926 190,374
Cash and cash equivalents and restricted cash at beginning of period 107,475 240
Cash and cash equivalents and restricted cash at end of period 447,401 190,614
Cash at beginning of period 107,475 240
Restricted cash at beginning of period 0 0
Cash and restricted cash at beginning of period 107,475 0
Cash at end of period 426,295 190,614
Restricted cash at end of period 21,106 0
Cash and restricted cash at end of period 447,401 190,614
Supplemental disclosure of cash flow information    
Cash paid for income taxes 0 0
Cash paid for interest 0 0
Supplemental disclosure of non-cash investing and financing activities    
Issuance of common stock pursuant to business combination 18,400,000 0
Contingent consideration liability recognized with business combination 2,300,000 0
Settlement of related party liabilities, Value 675,700 0
Issuance of common stock in settlement of liabilities $ 0 $ 88,100